Becton Dickinson

Becton Dickinson

Global medical devices and diagnostics provider

Field Service Technician

Full-TimeUpdated on 9/30/2026
No salary listed
Mid
Madison, WI, USA+1 more

More locations: Milwaukee, WI, USA

In Person

Regional travel, including overnight stays, is required; daily car travel averages approximately four hours.

About the job

Requirements
  • A high school diploma is required.
  • Three to five years of experience in a field service role is required.
  • Proficiency with multiple Microsoft operating systems, including Windows 2000, Windows XP, Windows 7, Windows 10, and Windows 11, and Microsoft Office applications.
  • Knowledge of basic computer networking, including using Windows tools to identify network and personal-computer information, configuring routers and switches, and locating and editing configuration and XML files.
  • Knowledge of ghosting and re-imaging processes.
  • Mechanical aptitude and ability to use standard hand tools for disassembly and reassembly of complex subsystems.
  • Proficiency with digital multimeters and voltage/amperage testers.
  • Ability to lift, carry, push, and pull up to 50 pounds frequently and up to 100 pounds occasionally.
  • Ability to stand for 10–12 hour shifts on occasion and perform frequent walking, climbing, balancing, stooping, kneeling, twisting, crouching, crawling, reaching, grasping, sitting, and standing.
  • Ability to travel by car daily and occasionally by air, including regional overnight travel.
  • Availability for weekend, holiday, and occasional overtime coverage.
  • Ability to work safely in varied pharmacy environments and navigate common workplace hazards.
Responsibilities
  • Deliver customer service and resolve problems at client sites while handling complaints and inquiries professionally.
  • Provide instruction on BD Parata pharmacy automation products, including operating procedures and daily maintenance requirements.
  • Respond to service requests within established service-level agreement timeframes.
  • Collaborate with regional and national service team members to identify and resolve complex technical issues.
  • Assist the Product Implementation Team with new automation installations when needed.
  • Document issue descriptions and resolution actions in Salesforce Field Service Lightning.
  • Travel regionally to provide technical and customer support and service to pharmacies in multiple environments.
Desired Qualifications
  • Proficiency with multiple Microsoft operating systems, including Windows 2000, Windows XP, Windows 7, Windows 10, and Windows 11, and Microsoft Office applications.
  • Knowledge of basic computer networking, including using Windows tools to identify network and personal-computer information, configuring routers and switches, and locating and editing configuration and XML files.
  • Knowledge of ghosting and re-imaging processes.
  • Mechanical aptitude and ability to use standard hand tools for disassembly and reassembly of complex subsystems.
  • Proficiency with digital multimeters and voltage/amperage testers.

About the company

BD is a global medical technology company serving hospitals, labs, and healthcare providers with products across BD Medical, Life Sciences, and Interventional. Its offerings include medication management and delivery devices, safe specimen collection and transport systems, and minimally invasive surgical instruments. Its products help safe medication administration, preserve specimen integrity for diagnostics, and enable less-invasive procedures, saving time and improving outcomes. BD differentiates itself with a broad end-to-end portfolio, global reach, and focus on quality, safety, and service to support care across regions; its goal is to improve patient outcomes, lower costs, and increase efficiency in care environments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Get referred to Becton Dickinson

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Third-quarter fiscal 2026 revenue reached $5.0 billion, up 5.4%, with raised guidance.
  • BD launched CentroVena One, HemoSphere Stream, and European Pyxis Pro in 2026.
  • Fairview's Vmax 160 deployment proves BD can win large health-system automation contracts.

What critics are saying

  • BD faces 3,250 implantable-port claims, with trials underway in Arizona through 2026.
  • FDA Class I recalls in August 2026 hit intraosseous sets and convenience kits.
  • Excellence Unleashed restructuring, $450 million impairments, and employee terminations signal deeper operational churn.

What makes Becton Dickinson unique

  • BD owns pharmacy automation, vascular access, and monitoring across inpatient care workflows.
  • BD's February 2026 Waters spin sharpened focus on medical technology and cash generation.
  • BD's AI-connected Pyxis Pro, Incada, and Research Cloud strengthen recurring platform differentiation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

↑ 10%

1 year growth

↑ 10%

2 year growth

↑ 10%
Class Action Lawyer TN
Sep 23rd, 2026
Compensation in a Tennessee Bard PowerPort Lawsuit.

Compensation in a Tennessee Bard PowerPort Lawsuit. Table of contents. Introduction to the Bard PowerPort Lawsuit. Compensation in a Tennessee Bard PowerPort Lawsuit: Types of compensation that may be available to plaintiffs who are meet the criteria for a PowerPort Lawsuit include both economical and non economical damages. * Tennessee Bard PowerPort Lawsuit: Asserts allegations that Bard's implantable port systems were defectively designed and manufactured, leading to serious injuries in patients who relied on them for long-term vascular access. * Link to Fractures and Blood Clots: These devices, widely used for chemotherapy, long-term IV treatments, and other infusion therapies, have been linked to catheter fractures, infections, blood clots, migration, and vessel damage. * Litigation Landscape: Thousands of injured patients across the country have filed lawsuits claiming that Bard Access Systems, Inc. and its parent company, Becton, Dickinson and Company, failed to properly warn healthcare providers and patients about these risks. * Exposure to Life-Threatening Compications: Plaintiffs allege that flaws in the catheter's material and construction allowed the device to degrade inside the body, exposing them to life-threatening complications and emergency surgeries. * Multidistrict Litigation: All federal Bard PowerPort catheter lawsuits have been consolidated in Multidistrict Litigation (MDL No. 3081) before the United States District Court for the District of Arizona. * Coordinated Pretrial Proceedings: This consolidation allows a single district court to coordinate pretrial proceedings, manage discovery, and set the stage for bellwether trials. * Compensation in Bard PowerPort Lawsuit: Through this litigation, plaintiffs are pursuing financial compensation for their medical expenses, pain and suffering, lost wages, and other damages resulting from defective Bard PowerPort catheter devices. If you or a loved one, sufferd injuries or worse as a result of a defective Bard PowerPort Device, call Tennessee Bard PowerPort Lawsuit Lawyer Timothy L. Miles today. You may be eligible for a PowerPort Lawsuit and potentially be entited to substantial compensation in Bard PowerPort Lawsuit. (855) 846-6529 or [email protected]. The Defective Bard Powerport Device. The Bard PowerPort is an implantable port catheter system used to deliver chemotherapy, fluids, and medications directly into a patient's bloodstream. Lawsuits allege that the catheter's polyurethane material is prone to degrading, cracking, and fracturing. * Catheter Fracture and Fragmentation: Shards of the catheter can chip off and travel through the vascular system. These plastic fragments can puncture blood vessels, the lungs, or the heart. * Life-Threatening Risks: The Defective Bard Powerport Device can cause cardiac punctures, cardiac arrhythmia, pulmonary embolisms (blood clots in the lungs), and severe internal bleeding. * Emergency Surgeries: If a Defective Bard Powerport Device causes port fractures or migrates, patients frequently requireemergency surgical extraction to remove the shards from their blood vessels or organs before fatal damage occurs. Bard PowerPort Lawsuit updates. Bard PowerPort litigation updates (sept. 2026). * Court: U.S. District Court, District of Arizona (Judge David G. Campbell) * Litigatin Process: Currently in the discovery process, including document production, depositions, and testing of explanted devices * Core Allegations: Design defects, failure to warn, and negligent manufacturing * Injuries Reported: Catheter fracture, device migration, blood clots, and severe infections leading to hospitalization or sepsis * Next Phase: Bellwether trials scheduled to evaluate representative cases and guide potential settlements The discovery process has focused heavily on engineering analyses, company testing records, and physician testimony about complications observed in clinical practice. Bellwether cases have been selected to move toward trial, where juries will assess whether Bard's design and warnings were adequate under federal product liability law. While verdicts in bellwether trials apply only to the individual plaintiffs involved, they play an important role in shaping the overall litigation. Jury responses to evidence of design defects and corporate negligence will influence both sides' settlement strategies and may drive the framework for financial compensation across the MDL. Who is eligible for a Bard PowerPort Lawsuit. You may qualify for a PowerPort Lawsuit, if you had a defective Bard PowerPort catheter devices, implanted and developed any of the following complications: * Perforations of tissues, vessels and organs * Infections (sepsis or septic shock) * Deep Vein Thrombosis (DVT) * Hemorrhaging or Bleeding Injuries * Fluid buildup on the heart * Irregular Heartbeat * Severe and persistent pain * Chemotherapy leaking into the body * Wrongful death * Other injuries caused by fractured PowerPort catheter Reports of Defective Bard Powerport Catheter Devices and patient. * Defective Bard Powerport Catheter Devices: Thousands of patients have reported complications involving a catheter failure, migration, and infection after receiving one of the Defective Bard Powerport Catheter Devices, * Polyurethane Catheter: In many cases, the polyurethane catheter - often made with a polymer blend called Chronoflex AL - has fractured or degraded over time. * Seveve Internal Injuries: Fragments of the defective Bard Powerport device,may travel through the blood vessels, leading to vascular damage, embolisms, and other internal injuries. * Emergency Medical Procedures: These failures have triggered emergency medical procedures and even permanent harm for affected users. * Structural Integrithy of Weakened Cathete: Experts argue that the material, which contains high concentrations of barium sulfate to improve imaging visibility, may weaken the structural integrity of the catheter over time. Bard PowerPort MDL continues to grow, with more than 3,000 pending Bard PowerPort Lawsuits filed. * The MDL is overseen by Judge Campbell in the District of Arizona, where the court continues to manage the case through recurring status conference proceedings and structured pretrial scheduling. * New Bard PowerPort Lawsuits are currently being filed by lawyers across the country. * If you were injured or suffered other Bard PowerPort complications, you may be qualify for a PowerPort Lawsuit and potentially be entitled to substantial compensation in Bard PowerPort Lawsuit. If you or a loved one, sufferd injuries or worse as a result of a defective Bard PowerPort Device, call Bard PowerPort Lawsuit Lawyer Timothy L. Miles today. You may be eligible for a PowerPort Lawsuit and potentially be entited to substantial compensation in Bard PowerPort Lawsuit. (855) 846-6529 or [email protected].

Parsippany Focus
Sep 22nd, 2026
Parsippany Engineer Dr. Trivikrama Reddy recognized with inaugural BD Community Excellence Award for global community impact.

Parsippany Engineer Dr. Trivikrama Reddy recognized with inaugural BD Community Excellence Award for global community impact. Sep 22, 2026 PARSIPPANY - Dr. Trivikrama Reddy, a Parsippany resident, Senior Staff Engineer at Becton, Dickinson and Company (BD), and Adjunct Professor at New Jersey Institute of Technology (NJIT), has been selected as an inaugural recipient of the BD Community Excellence Award, a global honor recognizing employees who have demonstrated exceptional commitment to improving communities through volunteerism, education, healthcare access, and sustainable development. The award celebrates BD associates who make a meaningful impact beyond their professional responsibilities by improving the lives of people in the communities where they live and work. According to BD, this year's recipients collectively strengthened healthcare access, expanded STEM education opportunities, supported vulnerable populations, and improved quality of life for people around the world. The award includes a $10,000 charitable grant awarded to a nonprofit organization selected by each recipient. Dr. Reddy was recognized for more than fifteen years of dedicated volunteer service supporting blood drives, health initiatives, STEM education programs, and community development projects. His most notable contribution was leading efforts to provide a sustainable and safe drinking-water solution to the tribal village of Rangasai in India, helping improve public health and reduce dependence on unsafe water sources. "Community service has always been an important part of my life," said Dr. Reddy. "I strongly believe that education, healthcare access, and clean water are fundamental necessities that can transform lives and create opportunities for future generations. I am honored to receive this recognition and grateful to everyone who supported these initiatives." Dr. Reddy's commitment to serving others extends across both his professional and academic careers. With more than 20 years of experience in medical device innovation and product development, he has contributed to technologies that improve patient outcomes worldwide. He currently serves as a Senior Staff Engineer at BD and is also an Adjunct Professor in the Mechanical Engineering Department at NJIT, where he has taught and mentored engineering students for the past eight years. In addition to his professional achievements, Dr. Reddy has actively promoted STEM education and community engagement through mentoring students, supporting educational programs, and encouraging young people to pursue careers in science, technology, engineering, and mathematics. "Dr. Reddy exemplifies the spirit of service and innovation," said Tom Polen, Chairman and Chief Executive Officer of BD. In recognizing this year's honorees, BD noted that recipients were selected for their leadership, dedication, and commitment to creating positive change in their communities. The company highlighted Dr. Reddy's efforts in improving community health, increasing access to safe water, and advancing STEM education as examples of meaningful and lasting impact. Beyond his engineering and educational contributions, Dr. Reddy has remained deeply involved in community service initiatives that create opportunities for underserved populations. His work reflects a belief that sustainable solutions and educational empowerment can have a lasting effect on individuals, families, and entire communities. The BD Community Excellence Award recognizes employees whose actions reflect the company's purpose of advancing health and improving lives. For Dr. Reddy, the recognition represents not only a personal achievement but also an affirmation of the collective efforts of volunteers, educators, healthcare professionals, and community leaders working together to make a difference. As he continues his professional, academic, and community service endeavors, Dr. Reddy hopes to inspire others to use their skills and expertise to address real-world challenges and create meaningful change in their communities.

Suttons Creek
Sep 22nd, 2026
Combination product industry news & guidance.

Combination product industry news & guidance. Sharing device-related information and wisdom that will help you succeed. Adam Kalbermatten on why combination products CAN'T be on the critical path. In this episode, Parth Kothari and Jonathan Amaya-Hodges sit down with Adam Kalbermatten, Chief Executive Officer at Koru Medical Systems, whose thirty-year career has spanned engineering programs at Becton Dickinson, global marketing leadership at Terumo, and building and scaling ZebraSci as CEO through its acquisition by BD. Now leading the commercial organization at Koru, Adam is focused on large-volume subcutaneous infusion and expanding the label for IG patients in the SCIG market. The conversation covers what actually reduces risk in combination product development, why pharma partners often underestimate the complexity they're introducing, and why the most important thing a device supplier can be is a partner rather than a vendor. Adam is direct about what keeps him up at night, what it takes to build a cross-functional team that actually works, and why the biggest mistake development programs make is ending up on the critical path in the first place. Key takeaways: * Following proven regulatory pathways beats developing custom specifications, almost every time * How to surface risk cross-functionally before it becomes a program-level problem * What the supplier-partner distinction means in practice - and where pharma companies get it wrong * Why combination products that land on the critical path rarely escape it Connect with Adam Kalbermatten on LinkedIn

PR Newswire
Sep 21st, 2026
Arthur Hu named BD's chief information and digital officer to drive AI adoption and transformation

BD has appointed Arthur Hu as executive vice president and chief information and digital officer, effective 30 September. Hu brings over 25 years of experience in global technology and digital transformation. He joins from Lenovo Group, where he served as senior vice president and global chief information officer. His responsibilities included leading digital technology, AI adoption and business transformation. Previously, he spent more than a decade at McKinsey & Company advising on technology and organisational transformation. BD chairman and CEO Tom Polen said Hu will help modernise the enterprise, embed AI into operations, and drive innovation. Hu will succeed Denise Russell Fleming, who retires at the end of 2026. BD is a global medical technology company with over 60,000 employees.

BD
Sep 21st, 2026
Arthur Hu to Join BD as Chief Information and Digital Officer

Arthur Hu to join BD as chief information and digital officer. FRANKLIN LAKES, N.J., Sept. 21, 2026 /PRNewswire/ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Arthur (Art) Hu has been named executive vice president and chief information and digital officer, effective September 30. Hu brings more than 25 years of experience leading global technology, digital and business transformation initiatives at scale. He joins BD from Lenovo Group, where he most recently served as senior vice president, global chief information officer and chief technology and delivery officer for the Solutions and Services Group. There, his responsibilities included leading digital technology, AI adoption and business transformation across customer, partner and employee-facing platforms. Prior to Lenovo, he spent over a decade at McKinsey & Company advising organizations on technology, operations, strategy and organizational transformation. Throughout his career, Hu has demonstrated the ability to connect technology to business outcomes, using digital capabilities to drive growth, improve execution and embed operational excellence. "Art is an exceptional technology and transformation leader with a proven track record of using digital, AI and automation to drive performance at scale," said Tom Polen, chairman, CEO and president of BD. "Bringing his depth of technology-sector experience to BD strengthens its leadership team and gives Becton, Dickinson and Company an important advantage as technology becomes increasingly central to how healthcare is delivered and how leading MedTech companies operate. Art will play a critical role in building a faster, more productive and more connected BD - modernizing its enterprise, embedding AI into how Becton, Dickinson and Company work, and translating technology into greater innovation and stronger business outcomes. Becton, Dickinson and Company is excited to have a leader of his caliber help shape the next chapter of BD and create even greater value for its customers, patients and shareholders. Hu will succeed Denise Russell Fleming, who will retire from BD at the end of 2026. About BD BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health(TM) by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with Becton, Dickinson and Company on LinkedIn at www.linkedin.com/company/bd1/, X @BDandCo or Instagram @becton_dickinson. | Contacts: | / | | Media | Investors | | Megan Dubrowski Senior Director, Executive Communications [email protected] | Shawn Bevec SVP, Investor Relations [email protected] | SOURCE BD (Becton, Dickinson and Company)